Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Geneva, Switzerland

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study – The Lancet

Related Commentary on Twitter

One of the best seroprevalence studies to date, just published @TheLancet: Serial (X5) assessment of IgG to #SARSCov2 in Geneva, a hard-hit region
—~10% max (each confirmed case -> 11.6X actual infections)
—kids (ages 5-9) much lower, relative protectionhttps://t.co/XCyQwVdRTl pic.twitter.com/bRJ5P9yKdW

— Eric Topol (@EricTopol) June 11, 2020